Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Assets (2019 - 2025)

Historic Assets for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $124360.0.

  • Bioadaptives' Assets rose 16805.77% to $124360.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $124360.0, marking a year-over-year increase of 16805.77%. This contributed to the annual value of $261885.0 for FY2024, which is 15181.73% up from last year.
  • Latest data reveals that Bioadaptives reported Assets of $124360.0 as of Q3 2025, which was up 16805.77% from $272515.0 recorded in Q2 2025.
  • Over the past 5 years, Bioadaptives' Assets peaked at $329302.0 during Q3 2023, and registered a low of $8735.0 during Q2 2024.
  • Moreover, its 5-year median value for Assets was $103998.0 (2023), whereas its average is $115061.2.
  • Per our database at Business Quant, Bioadaptives' Assets tumbled by 8591.17% in 2024 and then surged by 301980.54% in 2025.
  • Quarter analysis of 5 years shows Bioadaptives' Assets stood at $148585.0 in 2021, then crashed by 74.89% to $37314.0 in 2022, then surged by 178.71% to $103998.0 in 2023, then soared by 151.82% to $261885.0 in 2024, then tumbled by 52.51% to $124360.0 in 2025.
  • Its Assets was $124360.0 in Q3 2025, compared to $272515.0 in Q2 2025 and $110448.0 in Q1 2025.